SIRS-Lab produces molecular diagnostic systems to identify life-threatening infections. The main objective is early and targeted antibiotic therapy of sepsis, the leading cause of death in hospitals. More
SIFI is a 71-year old, privately owned pharmaceutical company specialised in ophthalmology. The company has three main business units: Pharma, Surgical, Diagnostic. More
The company is specialised in the development of immunological reagents (monoclonal antibodies) against biochemical markers of disease, and to use these reagents for development of laboratory tests More